Browsing Tag
MilliporeSigma
2 posts
Why Merck KGaA is spending $11.3bn on Bio-Techne instead of another drug pipeline
Merck KGaA plans to acquire Bio-Techne for $11.3 billion. Read why laboratory tools, recurring revenue and debt-funded growth could reshape its strategy.
MilliporeSigma invests over €300m in new South Korean bioprocessing center
MilliporeSigma, the Life Science business of Merck KGaA, Darmstadt, Germany, in the United States and Canada, has earmarked…